反应 #4097537
相关文献 (1)
openreactiondata ↗doi:10.1039/C8SC04228D
反应条件: temp:0.00; pressure:0.00; stir:
来源 ID: ord-065b07307f344e7ba6503d9ca2030a49暂无可渲染的结构数据
C1CCNC(C1)CCO产品信息
2-哌啶乙醇(CAS 1484-84-0)的产品身份、结构标识及相关反应资料,供化学中间体检索、研发和采购评估使用。
可能的应用方向
仅供专业研发与工业用途
数据库编号 15144
安全提示
仅供专业研发与工业用途。操作前请依据供应商提供的安全数据表完成风险评估。
合成路线数据
12 条反应 · 12 篇文献
反应条件: temp:0.00; pressure:0.00; stir:
来源 ID: ord-065b07307f344e7ba6503d9ca2030a49反应条件: temp:0.00; pressure:0.00; stir:
来源 ID: ord-a81917c9f54f4d5dad38382ed7323a69反应条件: temp:0.00; pressure:0.00; stir:
来源 ID: ord-999e4970a541446e83f75e35749927ea反应条件: temp:0.00; pressure:0.00; stir:
来源 ID: ord-8ce4030ae2824c2e80f47f730787c49c反应条件: temp:0.00; pressure:0.00; stir:
来源 ID: ord-5f15f02058a14146ad6935beac669d9a反应条件: temp:0.00; pressure:0.00; stir:
来源 ID: ord-72fd6aae4dab41bd99119229a5b57a77反应条件: temp:0.00; pressure:0.00; stir:; See reaction.notes.procedure_details.
实验步骤: A! A solution of 1N sodium hydroxide (156 ml, 0.156 mole) was added to a mixture of 2-piperidine-ethanol (20 ml, 0.156 mole) and butyl bromide (21 ml, 0.187 mole) in ethanol (200 ml). The reaction mixture was refluxed for 4 hours, then the solvent was evaporated under vacuum. The aqueous solution was acidified with HCl and washed with ethyl ether, then it was treated with a 32% solution of sodium hydroxide until pH-12 and extracted with ethyl ether. The combined organic phases were anhydrified over sodium sulfate and the solvent was evaporated under vacuum. The resulting crude was purified by distillation yielding 1.7 g of N-butyl-2-piperidine-ethanol (b.p.: 88°-99° C./0mmHg) (yield: 40%). The reaction mixture was refluxed for 4 hours the solvent was evaporated under vacuum washed with ethyl ether it was treated with a 32% solution of sodium hydroxide until pH-12 extracted with ethyl ether the solvent was evaporated under vacuum The resulting crude was purified by distillation
来源 ID: ord-ad793f1392ec4814b457edd404b3012a反应条件: temp:0.01; pressure:0.00; stir:; See reaction.notes.procedure_details.
实验步骤: 2-Piperidine ethanol (39.6 ml, 0.31 mol) was dissolved in 5M aq NaOH (62 ml, 0.31 mol) and dioxan (100 ml). The mixture was cooled to 0° C. and treated with benzyl chloroformate (45.3 ml, 0.32 mol) and 5M NaOH (62 ml, 0.31 mol). Stirring was continued at room temp. for 18 hours. Dioxan was removed in vacuo and the aqueous phase extracted with ether before acidifying with 5N HCl and extracting again with ether. The organic phase was dried and evaporated in vacuo and the residue purified by chromatography on silica gel to give the title compound (77.2 g. 95%). MH+ 264. Dioxan was removed in vacuo the aqueous phase extracted with ether extracting again with ether The organic phase was dried evaporated in vacuo the residue purified by chromatography on silica gel
来源 ID: ord-a73adbc824284e41a9fbe67c1543a175反应条件: temp:80.01; pressure:0.00; stir:; See reaction.notes.procedure_details.
实验步骤: The above synthesis may be carried out as follows: To DMF (100 ml) was added 4-chloro-2-imidazol-1-ylpyrimidine (0.50 g, 2.77 mmol), 2-piperidineethanol (0.359 g, 2.77 mmol), and Hünig's base (0.536 g, 4.15 mmol). After heating at 80° C. for 5 hours, the solvent was removed in vacuo and the residue was chromatographed (CH2Cl2/MeOH, 19/1) to give 349 mg (46%) of 1-[(1H-imidazol-1-yl)pyrimidin-4-yl]piperidine-2-ethanol (the compound of formula (XVI)), (1H NMR (CDCl3) δ8.54 (s, 2), 8.11 (d, 1), 7.82 (t, 1), 7.11 (d, 1), 6.44 (d, 1), 3.60 (m, 2), 3.03 (m, 1), 1.77 (m); MS: 2.74 (M+H)+). To a solution of 1-[(1H-imidazol-1-yl)pyrimidin-4-yl]piperidine-2-ethanol (25 mg, 0.092 mmol) dissolved in DMF (5 ml) was added NaH (60% dispersion in oil, 5.5 mg, 0.14 mmol) followed by piperonyl chloride (17 mg, 0.10 mmol) and t-butyl ammonium chloride. After stirring for 16 hours at 80° C., the solvent was removed in vacuo and the residue was partitioned with saturated NH4Cl and CH2Cl2. The organic layer was separated, dried (MgSO4), the solvent removed in vacuo, and the residue chromatographed (CH2Cl2/MeOH, 19/1) to give 13 mg (35%) of 4-[2-[[(1,3-benzodioxol-5-yl)methoxy]ethyl]piperidin -1-yl]-2-(1H-imidazol-1-yl)pyrimidine (the compound of formula (Icc)); 1H NMR (CDCl3) δ8.52 (s, 1), 8.05 (d, 1), 7.80 (s, 1), 7.09 (s, 1), 6.73 (m, 3), 6.45 (d, 1), 5.93 (s, 2), 4.30 (s, 2), 3.45 (m, 2),2.95 (m, 1), 1.55 (m); MS: 408.7 (M+H)+. The above synthesis the solvent was removed in vacuo the residue was chromatographed (CH2Cl2/MeOH, 19/1)
来源 ID: ord-db79c6d071bd4ae9975bbc070ab9b012反应条件: temp:60.01; pressure:0.00; stir:; See reaction.notes.procedure_details.
实验步骤: 3 g (14.7 mmol) of 2-chloro-3,5-dinitropyridine, 1.0 ml of THF and 30 mmol of 2-piperidinethanol were placed in a round-bottomed flask. The mixture was maintained at 60° C. for 15 hours with stirring and was then poured into an ice-water mixture with stirring. The precipitate formed was filtered off by suction and dried under vacuum to constant weight. 3.71 g of yellow powder were obtained. with stirring The precipitate formed was filtered off by suction dried under vacuum to constant weight
来源 ID: ord-c03ba15af6be48688c3b87477b808fc0反应条件: temp:0.00; pressure:0.00; stir:; See reaction.notes.procedure_details.
实验步骤: 2-(2-Hydroxyethyl)piperidine, HOBt and WSCI are added to N,N-dimethylformamide solution of 4-chlorobutyrate while being cooled with ice and the mixture is reacted at room temperature to obtain 1-(4-(chlorobutanoyl)-2-(2-hydroxyethyl)piperidine. while being cooled with ice the mixture is reacted at room temperature
来源 ID: ord-310f3313a8a242d199b178c88655ac08反应条件: temp:0.00; pressure:0.00; stir:; See reaction.notes.procedure_details.
实验步骤: 2-(2-Hydroxyethyl)piperidine, HOBt and WSCI are added to N,N-dimethylformamide solution of 4-chlorobutyrate while being cooled with ice and the mixture is reacted at room temperature to obtain 1-(4-(chlorobutanoyl)-2-(2-hydroxyethyl)piperidine. while being cooled with ice the mixture is reacted at room temperature
来源 ID: ord-310f3313a8a242d199b178c88655ac08PubChem References
以下资料来自该化合物的公开数据库参考记录。
相关产品
12 related records
CAS 27230-48-4
CAS 534595-53-4
CAS 21156-84-3
CAS 209329-11-3
CAS 68419-38-5
CAS 254104-05-7
CAS 73579-06-3
CAS 151490-32-3
CAS 3446-98-8
CAS 20845-34-5
CAS 284-18-4
CAS 13035-19-3
